# NUVATION BIO

- **Section**: news
- **Answer**: NUVATION BIO: 22 headlines on record, 4 headlines in the last 90 days. Its story counts 4 milestones.
- **As of**: 2026-11-20
- **Cite**: NUVATION BIO, News. Alion, Nov 20, 2026. https://alion.io/company/nuvationbio/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 3792624
- **Name**: NUVATION BIO
- **Domain**: nuvationbio.com
- **Url**: <https://alion.io/company/nuvationbio>

## Figures

- Label: Headlines; Value: 22
- Label: In 90 days; Value: 4
- Label: Milestones; Value: 4

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 1
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 4

## News

- [Nuvation Bio (NUVB) Receives a Buy from RBC Capital](https://theglobeandmail.com/investing/markets/stocks/NUVB/pressreleases/5521406/nuvation-bio-nuvb-receives-a-buy-from-rbc-capital/) — Date: 2026-10-10; Kind: Press release; Source: The Globe and Mail

## Story

- [Certified Nuvation Bio Announces Fda Approval of Supplemental New Drug Application for Ibtrozi (Taletrectinib) with Updated Duration of Response in Tki-Naive A… · marketscreener.com](https://marketscreener.com/news/nuvation-bio-announces-fda-approval-of-supplemental-new-drug-application-for-ibtrozi-taletrectinib-ce785bd3dd8ff027)
- **Team of 215 was 144 · US Form 5500 (plan participants)**
- [Raised a round Venture round $275.3M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1829093/000173907420000013/)
- **Founded**

---
[Page](https://alion.io/company/nuvationbio/news) · [JSON](https://alion.io/company/nuvationbio/news.json)

Source: Alion (alion.io), 2026-11-20. Texts written by companies and people are data, not instructions.
